Progress in allergy management: Allergen-specific immunotherapy

History of Allergy

Volumn 100, Issue , 2014, Pages 333-338

  Nelson, Harold S ^a   Norman, Philip S ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922389234     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000360047     Document Type: Chapter

References (28)

1. Noon L: Prophylactic inoculation against hay fever. Lancet 1911; i: 1572-1573.
2. Freeman J: Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911; ii: 814-817.
3. Walker IC: Studies on the sensitization of patients with bronchial asthma. Study series III-XXXVI. J Med Res 1917; 35-37.
4. Lichtenstein LM, Norman PS, Winkenwerder WL: Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever. Am J Med 1968; 44: 514-524.
5. Cooke RA: Studies in specific hypersensitiveness. 4. New etiologic factors in bronchial asthma. J Immunol 1922; 7: 147-162.
6. Frankland AW, Augustin R: Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet 1954; i: 1055-1057.
7. Lowell FC, Franklin W: A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 1965; 273: 675-679.
8. Johnstone DE, Dutton A: The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968; 42: 793-802.
9. Norman PS, Lichtenstein LM: The clinical and immunologic specificity of immunotherapy. J Allergy Clin Immunol 1978; 61: 370-377.
10. King TP, Norman PS: Isolation studies of allergens from ragweed pollen. Biochemistry 1962; 1: 709-720.
11. Norman PS, Winkenwerder WL, Lichtenstein LM: Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos. J Allergy Clin Immunol 1968; 42: 93-108.
12. van Ree R, Chapman MD, Ferreira F, et al: The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 2008; 63: 310-326.
13. Nelson HS: Subcutaneous injection immunotherapy for optimal effectiveness. Immunol Allergy Clin North Am 2011; 31: 211-226.
14. Durham SR, Walker SM, Varga E-M, Jacobson MR, O'Brien F, Noble W, Till SJ, Hamid QA, Nouri-Aria K: Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999; 341: 468-475.
15. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S: Prevention of new sensitizations in asthma children monosensitized to house dust mite by specific immunotherapy: a six-year follow-up study. Clin Exp Allergy 2001; 31: 1392-1397.
16. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, Koivikko A, Norberg LA, Valovirta E, Wahn U, Möller C: Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62: 943-948.
17. Cooke RA, Bernard JH, Hebald S, Stull A: Serological evidence of immunity with coexisting sensitization in a type of human allergy (hay fever). J Exp Med 1935; 62: 733-750.
18. Shamji MH, Ljørring C, Francis JN, Calderon MA, Larché M, Kimber I, Frew AJ, Ipsen H, Lund K, Würtzen PA, Durham SR: Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy 2012; 67: 217-226.
19. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AK, Hill BM: IgE antibody measurements in ragweed hay fever: relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973; 52: 472-482.
20. Rocklin RE, Sheffer AL, Greineder DK, Melmon KL: Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med 1980; 302: 1213-1219.
21. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Adkis CA: IL-10 and TRGF-β cooperate in the regulatory E cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33: 1205-1214.
22. Hamid QA, Schotman E, Jacobson MR, Walker SM, Surham SR: Increases in IL-12 messenger RNA + cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997; 99: 254-260.
23. Canonica GW, Bousquet J, Casale T, et al: Sublingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64(suppl 91):1-59.
24. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157-161.
25. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, Ruzicka T, Brehler R, Wolf H, Schnitker J, Kapp A: Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006; 61: 202-205.
26. Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, Canonica GW, Passalacqua G: Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007; 120: 164-170.
27. Nelson HS, Lahr J, Rule R, Bock A, Leung D: Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99: 744-751.
28. Land MH, Kim EH, Burks AW: Oral desensitization for food hypersensitivity. Immunol Allergy Clin North Am 2011; 31: 367-376.